Section 382 Rights Agreement Dated as of August 14, 2020 by and between ENZON PHARMACEUTICALS, INC. and CONTINENTAL STOCK TRANSFER & TRUST COMPANY as Rights AgentSection 382 Rights Agreement • August 14th, 2020 • Enzon Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledAugust 14th, 2020 Company Industry JurisdictionThis SECTION 382 RIGHTS AGREEMENT, dated as of August 14, 2020 (this “Agreement”), is made and entered into by and between Enzon Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation, as rights agent (the “Rights Agent”). Capitalized terms used herein and not otherwise defined shall have the meanings ascribed to them in Section 1 hereof.